AusPAR: Lucentis
Australian Public Assessment Report
Device/Product Name
Lucentis
Active ingredients
Ranibizumab
AusPAR Date
Published
Submission Number
PM-2020-04187-1-5
Submission Type
Extension of indications
Decision
Approved
This webpage on the TGA website was printed on 21 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/resources/auspar/auspar-lucentis